Search Results - "Pozzilli, P."

Refine Results
  1. 1

    Effect of diet on type 2 diabetes mellitus: a review by Khazrai, Y. M., Defeudis, G., Pozzilli, P.

    Published in Diabetes/metabolism research and reviews (01-03-2014)
    “…Type 2 diabetes mellitus is one of the fastest growing diseases; the number of people affected by diabetes will soon reach 552 million worldwide, with…”
    Get full text
    Journal Article
  2. 2

    Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review by Palermo, A., D’Onofrio, L., Eastell, R., Schwartz, A. V., Pozzilli, P., Napoli, N.

    Published in Osteoporosis international (01-08-2015)
    “…Fracture risk is higher in older adults with type 2 diabetes and may be influenced by treatments for diabetes. Oral anti-diabetic drugs have different effects…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Saxagliptin improves glycaemic control and C-peptide secretion in latent autoimmune diabetes in adults (LADA) by Buzzetti, R., Pozzilli, P., Frederich, R., Iqbal, N., Hirshberg, B.

    Published in Diabetes/metabolism research and reviews (01-03-2016)
    “…Background To assess the efficacy and tolerability of saxagliptin and C‐peptide secretion in patients with diagnosed type 2 diabetes classified as glutamic…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Diabetes and disordered bone metabolism (diabetic osteodystrophy): time for recognition by Epstein, S., Defeudis, G., Manfrini, S., Napoli, N., Pozzilli, P.

    Published in Osteoporosis international (01-06-2016)
    “…Summary Diabetes and osteoporosis are rapidly growing diseases. The link between the high fracture incidence in diabetes as compared with the non-diabetic…”
    Get full text
    Journal Article
  9. 9

    Differences between ATA, AACE/ACE/AME and ACR TI-RADS ultrasound classifications performance in identifying cytological high-risk thyroid nodules by Lauria Pantano, A, Maddaloni, E, Briganti, S I, Beretta Anguissola, G, Perrella, E, Taffon, C, Palermo, A, Pozzilli, P, Manfrini, S, Crescenzi, A

    Published in European journal of endocrinology (01-06-2018)
    “…Objective Thyroid ultrasound is crucial for clinical decision in the management of thyroid nodules. In this study, we aimed to estimate and compare the…”
    Get full text
    Journal Article
  10. 10

    The use of flash glucose monitoring significantly improves glycemic control in type 2 diabetes managed with basal bolus insulin therapy compared to self-monitoring of blood glucose: A prospective observational cohort study by Bosi, E., Gregori, G., Cruciani, C., Irace, C., Pozzilli, P., Buzzetti, R.

    Published in Diabetes research and clinical practice (01-01-2022)
    “…This prospective, observational cohort study aimed to measure HbA1c change over 3–6 months in type 2 diabetes managed with basal-bolus insulin and FreeStyle…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    In vivo corneal confocal microscopy as a novel non-invasive tool to investigate cardiac autonomic neuropathy in Type 1 diabetes by Maddaloni, E., Sabatino, F., Del Toro, R., Crugliano, S., Grande, S., Lauria Pantano, A., Maurizi, A. R., Palermo, A., Bonini, S., Pozzilli, P., Manfrini, S.

    Published in Diabetic medicine (01-02-2015)
    “…Aims To investigate whether small nerve fibre degeneration detected using corneal confocal microscopy is associated with cardiac autonomic neuropathy in people…”
    Get full text
    Journal Article
  14. 14

    Osteocalcin, glucose tolerance and diabetes by Pozzilli, P., Pr

    Published in Annales d'endocrinologie (01-09-2015)
    “…Osteocalcin (OCN), a marker of bone formation, is known to regulate glucose metabolism and influence the risk of developing adverse metabolic outcomes…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Diabetes on demand and novel technologies by Maurizi, A.R., Piemonte, V., Pozzilli, P.

    Published in Diabetes/metabolism research and reviews (01-02-2018)
    “…To date, the use of technology for the management of diabetes represents a promising area of innovation that can dramatically change diabetics' lives. In the…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Pre-culturing human adipose tissue mesenchymal stem cells under hypoxia increases their adipogenic and osteogenic differentiation potentials by Valorani, M. G., Montelatici, E., Germani, A., Biddle, A., D'Alessandro, D., Strollo, R., Patrizi, M. P., Lazzari, L., Nye, E., Otto, W. R., Pozzilli, P., Alison, M. R.

    Published in Cell proliferation (01-06-2012)
    “…Objectives Hypoxia is an important factor in many aspects of stem‐cell biology including their viability, proliferation, differentiation and migration. We…”
    Get full text
    Journal Article
  19. 19

    Age-dependent decline of β-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study by Barker, A., Lauria, A., Schloot, N., Hosszufalusi, N., Ludvigsson, J., Mathieu, C., Mauricio, D., Nordwall, M., Van der Schueren, B., Mandrup-Poulsen, T., Scherbaum, W. A., Weets, I., Gorus, F. K., Wareham, N., Leslie, R. D., Pozzilli, P.

    Published in Diabetes, obesity & metabolism (01-03-2014)
    “…Aims C‐peptide secretion is currently the only available clinical biomarker to measure residual β‐cell function in type 1 diabetes. However, the natural…”
    Get full text
    Journal Article
  20. 20